Martinot-Peignoux M - Search Results

1

The Usefulness of Defining Rapid Virological Response by a Very Sensitive Assay (TMA) during Treatment of HCV Genotype 2/3 Infection.

Dalgard O, Martinot-Peignoux M, Verbaan H, Bjøro K, Ring-Larsen H, Marcellin P. Dalgard O, et al. Among authors: martinot peignoux m. PLoS One. 2015 Aug 28;10(8):e0120866. doi: 10.1371/journal.pone.0120866. eCollection 2015. PLoS One. 2015. PMID: 26317978 Free PMC article.

2

IFI35, mir-99a and HCV genotype to predict sustained virological response to pegylated-interferon plus ribavirin in chronic hepatitis C.

Estrabaud E, Appourchaux K, Bièche I, Carrat F, Lapalus M, Lada O, Martinot-Peignoux M, Boyer N, Marcellin P, Vidaud M, Asselah T. Estrabaud E, et al. Among authors: martinot peignoux m. PLoS One. 2015 Apr 6;10(4):e0121395. doi: 10.1371/journal.pone.0121395. eCollection 2015. PLoS One. 2015. PMID: 25844942 Free PMC article.

3

Virological and serological tools to optimize the management of patients with chronic hepatitis B.

Martinot-Peignoux M, Marcellin P. Martinot-Peignoux M, et al. Liver Int. 2016 Jan;36 Suppl 1:78-84. doi: 10.1111/liv.12998. Liver Int. 2016. PMID: 26725902 Review.

4

Sustained virological response is associated with clearance of hepatitis C virus RNA and a decrease in hepatitis C virus antibody.

Maylin S, Martinot-Peignoux M, Ripault MP, Moucari R, Cardoso AC, Boyer N, Giuily N, Castelnau C, Pouteau M, Asselah T, Nicolas-Chanoine MH, Marcellin P. Maylin S, et al. Liver Int. 2009 Apr;29(4):511-7. doi: 10.1111/j.1478-3231.2008.01918.x. Epub 2008 Dec 9. Liver Int. 2009. PMID: 19076273 Free PMC article. Clinical Trial.

5

Early serum HBsAg drop: a strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients.

Moucari R, Mackiewicz V, Lada O, Ripault MP, Castelnau C, Martinot-Peignoux M, Dauvergne A, Asselah T, Boyer N, Bedossa P, Valla D, Vidaud M, Nicolas-Chanoine MH, Marcellin P. Moucari R, et al. Hepatology. 2009 Apr;49(4):1151-7. doi: 10.1002/hep.22744. Hepatology. 2009. PMID: 19115222

6

Virological response at 4 weeks to predict outcome of hepatitis C treatment with pegylated interferon and ribavirin.

Martinot-Peignoux M, Maylin S, Moucari R, Ripault MP, Boyer N, Cardoso AC, Giuily N, Castelnau C, Pouteau M, Stern C, Aupérin A, Bedossa P, Asselah T, Marcellin P. Martinot-Peignoux M, et al. Antivir Ther. 2009;14(4):501-11. Antivir Ther. 2009. PMID: 19578235 Clinical Trial.

7

Clinical performances of two real-time PCR assays and bDNA/TMA to early monitor treatment outcome in patients with chronic hepatitis C.

Martinot-Peignoux M, Khiri H, Leclere L, Maylin S, Marcellin P, Halfon P. Martinot-Peignoux M, et al. J Clin Virol. 2009 Nov;46(3):216-21. doi: 10.1016/j.jcv.2009.08.011. Epub 2009 Sep 12. J Clin Virol. 2009. PMID: 19748822

8

Influence of genotype on hepatitis B surface antigen kinetics in hepatitis B e antigen-negative patients treated with pegylated interferon-alpha2a.

Moucari R, Martinot-Peignoux M, Mackiewicz V, Boyer N, Ripault MP, Castelnau C, Leclere L, Dauvergne A, Valla D, Vidaud M, Nicolas-Chanoine MH, Marcellin P. Moucari R, et al. Antivir Ther. 2009;14(8):1183-8. doi: 10.3851/IMP1458. Antivir Ther. 2009. PMID: 20032548

9

Twelve weeks posttreatment follow-up is as relevant as 24 weeks to determine the sustained virologic response in patients with hepatitis C virus receiving pegylated interferon and ribavirin.

Martinot-Peignoux M, Stern C, Maylin S, Ripault MP, Boyer N, Leclere L, Castelnau C, Giuily N, El Ray A, Cardoso AC, Moucari R, Asselah T, Marcellin P. Martinot-Peignoux M, et al. Hepatology. 2010 Apr;51(4):1122-6. doi: 10.1002/hep.23444. Hepatology. 2010. PMID: 20069649

10

Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: incidence and survival in hepatitis C patients with advanced fibrosis.

Cardoso AC, Moucari R, Figueiredo-Mendes C, Ripault MP, Giuily N, Castelnau C, Boyer N, Asselah T, Martinot-Peignoux M, Maylin S, Carvalho-Filho RJ, Valla D, Bedossa P, Marcellin P. Cardoso AC, et al. J Hepatol. 2010 May;52(5):652-7. doi: 10.1016/j.jhep.2009.12.028. Epub 2010 Mar 4. J Hepatol. 2010. PMID: 20346533

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

104 results

Search Page